Cartilage-hair hypoplasia syndrome: Increased apoptosis of T lymphocytes is associated with altered expression of fas (CD95), FasL (CD95l), IAP, Bax, and Bcl2

Journal of Clinical Immunology

Volumn 19, Issue 6, 1999, Pages 428-434

  Yel, Leman ^a   Aggarwal, Sudeepta ^a   Gupta, Sudhir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bax; Bcl 2; Cartilage hair hypoplasia; Cytokines; Fas; FasL; T cell subsets

Indexed keywords

FAS ANTIGEN; PROTEIN BAX; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CARTILAGE HYPOPLASIA; CASE REPORT; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTOPENIA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT LIMBED DWARFISM; T LYMPHOCYTE;

EID: 0033428150     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020563018864     Document Type: Article

References (37)

1. 1. McKusick VA: Metaphyseal dysostosis and thin hair: A "new" recessively inherited syndrome? Lancet 1:832-833, 1964
2. 2. Van der Burgt I, Haraldsson A, Oosterwijk JC, Van Essen AJ, Weemaes C, Hamel B: Cartilage hair hypoplasia, metaphyseal chondrodysplasia type McKusick: Description of seven patients and review of the literature. Am J Med Genet 41:371-380, 1991
3. 3. Mäkitie O, Kaitila I: Cartilage-hair hypoplasia-clinical manifestations in 108 Finnish patients. Eur J Pediatr 152:211-217, 1993
4. 4. Mäkitie O, Sulisalo T, de la Chapelle A, Kaitila I: Cartilage-hair hypoplasia. J Med Genet 32:39-43, 1995
5. 5. Ranki A, Perheentupa J, Andersson LC, Hayry P: In vitro T-and B-cell reactivity in cartilage hair hypoplasia. Clin Exp Immunol 32:352-360, 1978
6. 6. Virolainen M, Savilahti E, Kaitila I, Perheentupa J: Cellular and humoral immunity in cartilage-hair hypoplasia. Pediatr Res 12: 961-966, 1978
7. 7. Polmar SH, Pierce GF: Cartilage hair hypoplasia: Immunological aspects and their clinical implications. Clin Immunol Immunopathol 40:87-93, 1986
8. 8. Mäkitie O, Kaitila T, Savilahti E: Susceptibility to infections and in vitro immune functions in cartilage-hair hypoplasia. Eur J Pediatr 157:816-820, 1998
9. 9. Sulisalo T, Sistonen P, Hästbacka J, Wadelius C, Mäkitie O, de la Chapelle A, Kaitila I: Cartilage-hair hypoplasia gene assigned to chromosome 9 by linkage analysis. Nature Gene 3:338-341, 1993
10. 10. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306, 1980
11. 11. Osborne BA. Apoptosis and the maintenance of homeostasis in the immune system. Curr Opin Immunol 8:245-254, 1996
12. 12. Ashkenazi A, Dixit VM: Death receptors: Signaling and modulation. Science 281:1305-1308, 1998
13. 13. Cohen JJ: Apoptosis and its regulation. Adv Exp Med Biol 406:11-20, 1996
14. 14. Oehm AI, Gehrmann W, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstingl H, Krammer PH: Purification and molecular cloning of the Apo-1 cell surface antigen, a member of tumor necrosis factor/nerve growth factor receptor super family. Sequence identity with the Fas antigen. J Biol Chem 267:10709-10715, 1992
15. 15. Suda T, Takahashi T, Goldstein P, Nagutu S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
16. 16. Nagata S, Goldstein P: The Fas death factor. Science 267:1499-1506, 1995
17. 17. Suda T, Nagata S: Purification and characterization of the FasL that induces apoptosis. J Exp Med 179:873-879, 1994
18. 18. Dhein J, Danier Pt, Traub BC, Oehm A, Moller P. Krammer PH: Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigen. J Immunol 149:3166-3173, 1992
19. 19. Adams JM, Cory S: The Bcl-2 protein family: Arbiters of cell survival. Science 281:1322-1326, 1998
20. 20. Mäkitie O, Perheentupa J, Kaitila I: Growth in cartilage-hair hypoplasia. Pediatr Res 31:176-180, 1992
21. 21. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
22. 22. Ammann AJ, Sutliff W, Millinchick E: Antibody-mediated immunodeficiency in short-limbed dwarfism. J Pediatr 84:200-203, 1974
23. 23. Saulsbury FT, Winkelstein JA, Davis LE, Hsu SH, D'Souza BJ, Gutcher, Butler IJ: Combined immunodeficiency and vaccine-related poliomyelitis in a child with cartilage-hair hypoplasia. J Pediatr 86:868-872, 1975
24. 24. Berthet F, Siegrist CA, Ozsahin H, Tuchschmid P, Eich G, Superti-Furga A, Seger RA: Bone marrow transplantation in cartilage-hair hypoplasia: Correction of the immunodeficiency but not of the chondrodysplasia. Eur J Pediatr 155.-286-290, 1996
25. 25. Mäkitie O, Pukkala E, Teppo L, Kaitila I: Increased incidence of cancer in patients with cartilage-hair hypoplasia. J Pediatr 134: 315-318, 1999
26. 26. Trojak JE, Polmar SH, Winkelstein JA, Hsu S, Francomano C, Pierce GF, Scillian JJ, Gale AN, McKusick VA: Immunologic studies of cartilage-hair hypoplasia in the Amish. Johns Hopkins Med J 148:157-164, 1981
27. 27. Pierce GF, Polmar SH: Lymphocyte dysfunction in cartilage-hair hypoplasia: Evidence for an intrinsic defect in cellular proliferation. J Immunol 129:570-575, 1982
28. 28. Pierce GF, Polmar SH: Lymphocyte dysfunction in cartilage hair hypoplasia. II. Evidence for a cell cycle specific defect in T cell growth. Clin Exp Immunol 50:621-628, 1982
29. 29. Kooijman R, Van Der Burgt CJAM, Weemaes CMR, Haraldsson A, Scholtens EJ, Zegers BJM: T cell subsets and T cell function in cartilage-hair hypoplasia. Scand J Immunol 46:209-215, 1997
30. 30. Castigli E, Irani AM, Geha RS, Chatila T: Defective expression of early activation genes in cartilage-hair hypoplasia (CHH) with severe combined immunodeficiency (SCID). Clin Exp Immunol 102:6-10, 1995
31. 31. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71-77, 1995
32. 32. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14:1129-1135, 1995
33. 33. Oyaizu N. and Pahwa S: Role of apoptosis in HIV disease pathogenesis. J Clin Immunol 15:217-231, 1995
34. 34. Gupta S, Aggarwal S, Nguyen T: Increased spontaneous apoptosis in T lymphocytes in DiGeorge anomaly. Clin Exp Immunol 113:65-71, 1998
35. 35. Aggarwal S. and Gupta S: Increased apoptosis of T cell subsets in aging humans: Altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol 160:1627-1637, 1998
36. 36. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nag S: Expression of the Fas ligand in cells of T cell lineage. J Immunol 154:3806-3813, 1995
37. 37. Deveraux QL. Reed JC: IAP family proteins-suppressors of apoptosis. Genes Dev 13:239-252, 1999